Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Fingerprick Autologous Blood (FAB) in the Treatment of Mebomian Gland Dysfunction (MGD)

NCT02943382 is registered in ClinicalTrials.gov with Bedford Hospital NHS Trust as lead sponsor.

NCT NCT02943382
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02943382 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Fingerprick Autologous Blood (FAB) in the Treatment of Mebomian Gland Dysfunction (MGD)
Lead sponsor
Bedford Hospital NHS Trust
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 2016
Completion date
September 30, 2019
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye disease, meibomian gland dysfunction